Immunohistochemical Double-Hit Score Is a Strong Predictor of Outcome in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and PrednisoneTina Green, Michael Møller, Ole Nielsen et al.|Journal of Clinical Oncology|2012Cited by 682
Real-world outcomes with ibrutinib in relapsed or refractory mantle cell lymphoma: a Danish population-based studyTrine Trab, Kirsten Grønbæk, Iman Chanchiri et al.|Blood Neoplasia|2025Cited by 4
Real-World Outcomes for Patients Treated with Ibrutinib for Relapsed/Refractory Mantle Cell Lymphoma in DenmarkTrine Trab, Kirsten Grønbæk, Iman Chanchiri et al.|Blood|2024Cited by 0